Dynavax Technologies Corp (DVAX)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Ryan Spencer
Employees:
350
2100 POWELL STREET, SUITE 720, EMERYVILLE, CA, 94608
5108485100
Date | Ratio |
---|---|
2014-11-10 | 1:10 |
The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in the vaccine. The company was formerly known as Double Helix Corporation.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|